Evaluation of BMP-2 gene-activated muscle grafts for cranial defect repair

Journal of Orthopaedic Research

Volumn 30, Issue 7, 2012, Pages 1095-1102

  Liu, Fangjun ^a,b   Porter, Ryan M ^a,b   Wells, James ^a,b   Glatt, Vaida ^a   Pilapil, Carmencita ^b   Evans, Christopher H ^a,b,c  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c AO FOUNDATION   (Switzerland)

Author keywords

BMP 2; bone healing; gene therapy; muscle; osteogenesis

Indexed keywords

ADENOVIRUS VECTOR; BONE MORPHOGENETIC PROTEIN 2; COMPLEMENTARY DNA; GREEN FLUORESCENT PROTEIN;

ANIMAL TISSUE; ARTICLE; BONE DENSITY; CALVARIA; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; GENE ACTIVATION; HISTOPATHOLOGY; HUMAN; IN VIVO STUDY; MALE; MICRO-COMPUTED TOMOGRAPHY; MUSCLE BIOPSY; MUSCLE GRAFT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SKULL DEFECT; SKULL RADIOGRAPHY;

ADENOVIRIDAE; ANIMALS; BONE DISEASES; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; CELL DIFFERENTIATION; GENE THERAPY; MALE; MUSCLE, SKELETAL; OSTEOBLASTS; OSTEOGENESIS; RATS; RATS, INBRED F344; SKULL; TRANSGENES;

EID: 84861093818     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.22038     Document Type: Article

References (27)

1. Evans CH,. 2010. Gene therapy for bone healing. Expert Rev Mol Med 12: e18. DOI: 10.1017/S1462399410001493.
2. Evans CH, Palmer GD, Pascher A, et al. 2007. Facilitated endogenous repair: making tissue engineering simple, practical, and economical. Tissue Eng 13: 1987-1993.
3. Shore EM, Kaplan FS,. 2008. Insights from a rare genetic disorder of extra-skeletal bone formation, fibrodysplasia ossificans progressiva (FOP). Bone 43: 427-433.
4. Stoltny T, Koczy B, Wawrzynek W, et al. 2007. Heterotopic ossification in patients after total hip replacement. Ortop Traumatol Rehabil 9: 264-272.
5. Covey DC,. 2006. Combat orthopaedics: a view from the trenches. J Am Acad Orthop Surg 14: S10-S17.
6. Shore EM, Xu M, Feldman GJ, et al. 2006. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Nat Genet 38: 525-527.
7. Bosch P, Musqrave DS, Lee JY, et al. 2000. Osteoprogenitor cells within skeletal muscle. J Orthop Res 18: 933-944.
8. Kuroda R, Usas A, Kubo S, et al. 2006. Cartilage repair using bone morphogenetic protein 4 and muscle-derived stem cells. Arthritis Rheum 54: 433-442.
9. Evans CH, Liu FJ, Glatt, V, et al. 2009. Use of genetically modified muscle and fat grafts to repair defects in bone and cartilage. Eur Cell Mater 18: 96-111.
10. Velardi F, Amante PR, Caniglia M, et al. 2006. Osteogenesis induced by autologous bone marrow cells transplant in the pediatric skull. Childs Nerv Syst 22: 1158-1166.
11. Szpalski C, Barr J, Wetterau M, et al. Cranial bone defects: current and future strategies. Neurosurg Focus 29: E8.
12. Lemperle SM, Calhoun CJ, Curran RW, et al. 1998. Bony healing of large cranial and mandibular defects protected from soft-tissue interposition: a comparative study of spontaneous bone regeneration, osteoconduction, and cancellous autografting in dogs. Plast Reconstr Surg 101: 660-672.
13. Ripamonti U, Bosch C, van den Heeyer B, et al. 1996. Limited chondro-osteogenesis by recombinant human transforming growth factor-beta 1 in calvarial defects of adult baboons (Papio ursinus). J Bone Miner Res 11: 938-945.
14. Tanaka T, Taniquchi Y, Gotoh K, et al. 1993. Morphological study of recombinant human transforming growth factor beta 1-induced intramembranous ossification in neonatal rat parietal bone. Bone 14: 117-123.
15. Hardy S, Kitamura M, Harris-Stansil T, et al. 1997. Construction of adenovirus vectors through Cre-lox recombination. J Virol 71: 1842-1849.
16. Gouze JN, Stoddart MJ, Gouze E, et al. 2004. In vitro gene transfer to chondrocytes and synovial fibroblasts by adenoviral vectors. Methods Mol Med 100: 147-164.
17. Palmer GD, Gouze E, Gouze JN, et al. 2003. Gene transfer to articular chondrocytes with recombinant adenovirus. Methods Mol Biol 215: 235-246.
18. Livak KJ, Schmittgen TD,. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
19. Schmitz JP, Hollinger JO,. 1986. The critical size defect as an experimental model for craniomandibulofacial nonunions. Clin Orthop Relat Res 205: 299-308.
20. Ueno T, Kagawa T, Kanou M, et al. 2004. Pathological change of articular cartilage in the mandibular head treated with immunosuppressant FK 506. Histol Histopathol 19: 15-21.
21. Kawana F, Sawae Y, Sahara T, et al. 2001. Porcine enamel matrix derivative enhances trabecular bone regeneration during wound healing of injured rat femur. Anat Rec 264: 438-446.
22. Crofford LJ, McDonagh KT, Guo S, et al. 2005. Adenovirus binding to cultured synoviocytes triggers signaling through MAPK pathways and induces expression of cyclooxygenase-2. J Gene Med 7: 288-296.
23. Hassel S, Schmitt S, Hartunq A, et al. 2003. Initiation of Smad-dependent and Smad-independent signaling via distinct BMP-receptor complexes. J Bone Joint Surg Am 85-A: 44-51.
24. Peng H, Wright V, Usas A, et al. 2002. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest 110: 751-759.
25. Gerber HP, Vu TH, Rvan AM, et al. 1999. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5: 623-628.
26. Evans CH, Ghivizzani SC, Robbins PD,. 2012. Orthopedic gene therapy€"lost in translation? J Cell Physiol 227: 416-420.
27. Sheridan C,. Gene therapy finds its niche. Nat Biotechnol 29: 121-128.